Novo Nordisk’s bispecific antibody Mim8 prevented bleeding events and caused no adverse safety events in the Phase III FRONTIER3 trial. The company plans to file for approval this year, hoping to ...

Dan Roche and Joe Weil discuss the upcoming battle for second between the two young players if the team does not sign Alex Bregman.

"There isn’t enough being done – regardless of whether you’re an islander or mainlander. People feel left behind," the IFA's ...

Dermatologists explain what kojic acid is and the benefits of using it. Shop products with kojic acid from Amazon, Target, ...

Roche Bobois debuts at Royalmount in Montreal, offering a 6,300 sq. ft. showroom with custom furnishings, 3D design services, ...

Custom duty waiver for expensive cancer drugs doesn't address high prices due to patent monopolies, offering minimal relief ...

The Fergus girls basketball team earned their second conference win of the season with a home victory over Sidney on Saturday, Feb. 1. Kiya Foran had a strong shooting night ...

Residents have been invited to participate in a series of engaging events as the Bermuda College focuses on science next week ...

Novo Nordisk's hemophilia A drug Mim8 shows success in pediatric trial, Mim8 could compete with Roche's Hemlibra, with plans for regulatory filing this year.

Almost 16 years after Rituxan's disappointing data in lupus, Roche's Genentech found success with a different B cell-killing ...

The Koochiching Economic Development Authority will consider a request from a newly-organized group about the role it will play in its future. The KEDA Board Thursday asked that Director Paul ...

Various University of Richmond players during the season drop by for uncompensated visits at Discovery Village at the West ...